Lampire Covid-19 Antibodies
LAMPIRE has added COVID-19 recombinant proteins and RNA lysis buffer to its product portfolio. These components of SARS CoV-2 include full-length trimeric peak, S1 glycoproteins, nucleocapsid, receptor-binding domain, and ACE2 proteins.
These proteins are NOW AVAILABLE for research use only. Count on LAMPIRE as your critical research partner in the fight against COVID-19. Ask about additional LAMPIRE products and services related to the pandemic investigation.
The COVID-19 antibody test, also known as a serological test, is a blood test that is performed to find out if you have had a previous infection with SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID- 19). An antibody test cannot determine if you are currently infected with the COVID-19 virus.
Antibodies are proteins made by your immune system in response to infection. Your immune system, which involves a complex network of cells, organs, and tissues, identifies foreign substances in your body and helps fight infection and disease. After infection with the COVID-19 virus, it can take two to three weeks to develop enough antibodies to be detected in an antibody test, so it is important not to get tested too early.
Antibodies may be found in your blood for several months or longer after you recover from COVID-19. Although these antibodies likely provide some immunity to the COVID-19 virus, there is currently not enough evidence to know how long the antibodies last or how much previous infection with the virus helps protect you from getting another infection. Although rare, there are some confirmed and suspected cases of reinfection. Studies are underway on COVID-19 antibodies and other components of the immune system to learn more about immunity.
Antibody tests can detect certain types of antibodies related to the COVID-19 virus:
Antibody binding. These widely available antibody tests detect if you have developed any antibodies in response to a COVID-19 infection. But they do not indicate how extensive or effective your immune response is.
Neutralizing antibodies. Not widely available yet, a newer and more sensitive test detects a subset of antibodies that can inactivate the virus. This test can be done after a positive binding antibody test. It’s another step in finding out how effective your antibodies are at blocking the virus to help protect you from another COVID-19 infection.